View all IQVIA events
                    
                        
                
 
                                                 
                                                 
                                                 
                                                 
                                                 
                                                 
                                         
                                         
                                         
                                     
                                    
 
                                                                 
                                                                 
                                                                 
                                                                 
                                                                 
                                                                 
                                                                 
                                             
                                             
                                             
                                                 
                                            The ongoing impact of COVID-19 on health services across Europe has led to significant reductions in cancer screening, testing and diagnosis. Delays in diagnosis are already impacting cancer treatment and survival and are likely to continue for years to come. Responses to the pandemic have differed within individual countries and for specific tumour groups, with some countries responding exceptionally well under the circumstances. We will look into the situation in the Nordics.
This webinar will highlight:
 
                                